Chronic Idiopathic Myelofibrosis clinical trials at UCSF
1 in progress, 1 open to new patients
open to eligible people ages 18 years and up
This study is a dose escalation, and cohort expansion study in subjects with advanced cancer for which no standard therapy exists. Subjects must have received prior treatment for cancer that has not worked, or has stopped working.
San Francisco, California and other locations